Roche gets boost on Avastin in lung cancer; Teva settles Medicare fraud probes for $169M;

 @FiercePharma: Decentralized NHS could be a sales-rep boon. Report | Follow @FiercePharma

> Some good Avastin news: the Roche drug won a renewed endorsement as a treatment for lung cancer from a clinical study looking at the drug's use in a broad, real-life setting. Story

> From a $169 million multistate settlement of Medicare fraud probes, Texas will receive $51.4 million from Teva Pharmaceutical, Attorney General Greg Abbott said. Report

> Abbott Laboratories (ABT.N) reported slightly higher-than-expected quarterly earnings, with strong sales growth from its array of prescription drugs, medical devices and nutritional products. News

> Anti-HIV drug maker Gilead Sciences said its second-quarter net income rose 25 percent, driven by sales of its antiviral drugs, but the results were short of expectations. Report

> Forest Laboratories' (FRX) fiscal first-quarter profit slumped 55 percent on litigation charges and product-licensing fees; sales improved and results beat analysts' expectations. Article

> Eli Lilly's price tag for Alnara Pharma could be as high as $380 million if the smaller company meets certain regulatory and commercial milestones. Report

> Reckitt Benckiser agreed to buy Durex condom maker SSL International for £2.54 billion ($3.9 billion), bolstering its health and personal-care business in the biggest acquisition since the company was formed in 1999. Story

> Mylan, the third-biggest generic drugmaker in the world, is spending €67 million on a packaging plant in the Hungarian city of Komarom, the company said Tuesday. Article

Biotech News

 @FierceBiotech: Study: Ecstacy may be useful in PTSD therapy. Report | Follow @FierceBiotech

> Merck buys vax unit from bankrupt Hawaii Biotech. Story

> Cara rounds up $15M for post-op pain drug. News

> Shionogi, GSK move HIV drug into PhIII. Article

Medical Device News

> J&J posts lower-than-expected earnings. Report

> Mass. students create portable ventilator. Story 

> Cardiac Science to replace faulty defibrillators. News

Drug Delivery News

> DOD taps Tekmira for Ebola treatment. Story

> Drug delivery expert helps Taris through bladder disease trials. Piece

> Access Pharma uses Trojan Horse to sneak into oral insulin. More

And Finally... Horses and polar bears and lizards, oh my! Check out the most interesting logos in biopharma. Slideshow